Max Liu, MD, PhD — Chief Scientific Officer

Dr. Guang Hao “Max” Liu blends clinical expertise, scientific research, and technological insight to guide VKunMeds’ innovation strategy. Holding MD and PhD degrees from the University of Iowa with advanced training in neuroscience and neurology, Max bridges breakthrough science and practical healthcare solutions.

As Chief Scientific Officer, he leads VKunMeds in identifying cutting-edge technologies and high-impact products to invest in and distribute. His evidence-based approach ensures every innovation the company adopts delivers real benefits to patients, providers, and the healthcare system.

Yalin Zhao — Co-Founder & CEO

Yalin Zhao is a trailblazing healthcare innovator and the driving force behind VKunMeds. With a career rooted in clinical excellence and a passion for solving systemic challenges, she founded 52Meds, a pioneering platform addressing the nursing shortage in the U.S., positively impacting healthcare systems and empowering nursing professionals nationwide. A proud graduate of Columbia University School of Nursing and an honoree of the Nursing Leader Society, Yalin also holds an engineering degree from Cornell University, combining technical problem-solving with frontline clinical experience to create scalable solutions for healthcare.